American College of Clinical Pharmacy
      Search      Cart
         

PSAP in JACCP - Part I: Interactive Case: Precision Medicine in Psychiatry and Part II: Interactive Case: Clinical Pearls of Clozapine - 2023 March


Member Price:
$29.95
Nonmember Price:
$29.95

Faculty Information

PSAP in JACCP features are developed from activities presented as part of the Pharmacotherapy Self-Assessment Program (PSAP).

Part I: Interactive Case: Precision Medicine in Psychiatry

This feature was developed from an interactive case presented in PSAP 2022 Book 3 (Behavioral Health).

  • Interactive Case: Click here to access the interactive case.
Part II: Interactive Case: Clinical Pearls of Clozapine

This feature was developed from an interactive case presented in PSAP 2022 Book 3 (Behavioral Health).

  • Interactive case: Click here to access the interactive case.

Author - Reviewer Information

Part I: Interactive Case: Precision Medicine in Psychiatry

Authors: Jonathan F. Lister, Pharm.D., BCPP; and Kara R. Wong, Pharm.D., BCPP
Reviewed by: Jacob T. Brown, Pharm.D., MS; Rizah Anwar Assadi, Pharm.D., BCPS; and Michelle Ganoff, Pharm.D., BCPS

Part II: Interactive Case: Clinical Pearls of Clozapine

Author: Jonathan G. Leung, Pharm.D., BCPS, BCPP
Reviewed by: Erica Davis, Pharm.D., BCPS, BCPP; Alisa Brown Chamblee, Pharm.D., BCPS; and Asmaa Kamal Mohammed, Pharm.D., BCPS

Target Audience and Learning Objectives

Part I: Interactive Case: Precision Medicine in Psychiatry

Target audience for this application-based activity:
Pharmacotherapy specialists and advanced level clinical pharmacists managing diverse patient populations.

Learning Objectives

  1. Evaluate the evidence and guideline recommendations for pharmacogenomic (PGx) testing and therapeutic drug monitoring (TDM) in psychiatry.
  2. Distinguish when a patient may benefit from PGx testing and TDM in psychiatry.
  3. Assess psychiatric PGx and TDM results in a patient with mental illness.
  4. Develop a treatment plan, including patient counseling, using PGx and/or TDM results for a patient with mental illness
Part II: Interactive Case: Clinical Pearls of Clozapine

Target audience for this application-based activity:
Pharmacotherapy specialists and advanced level clinical pharmacists managing diverse patient populations.

Learning Objectives

  1. Develop a treatment plan involving clozapine using current evidence and clinical guidelines.
  2. Assess patients for clinically relevant drug interactions with clozapine.
  3. Justify the role of monitoring clozapine and norclozapine serum concentrations in clinical practice.
  4. Account for potential clozapine-related adverse events during and after an acute hospital admission

Disclosure of Potential Conflicts of Interest

Part I: Interactive Case: Precision Medicine in Psychiatry

Kara R. Wong: Consultancies (CPNP Recertification Editorial Board); Honoraria (College of Psychiatric and Neurologic Pharmacists)
Nothing to disclose: Rizah Anwar Assadi, Jacob T. Brown, Michelle Ganoff, Jonathan F. Lister

Part II: Interactive Case: Clinical Pearls of Clozapine

Jonathan G. Leung: Consultancies (Wolters-Kluwer)
Nothing to disclose: Erica Davis, Alisa Brown Chamblee, Asmaa Kamal Mohammed

Continuing Pharmacy Education and Recertification Instructions

Available CPE/Recertification credits: Anyone who purchases, successfully completes and passes the required posttests for this feature can earn up to 3.0 contact hours of CPE/Recertification credit.

Part I: Interactive Case: Precision Medicine in Psychiatry

Universal Activity Number: 0217-0000-23-009-H01-P
1.5 CPE contact hours
Application-Based Activity

Part II: Interactive Case: Clinical Pearls of Clozapine

Universal Activity Number: 0217-0000-23-010-H04-P
1.5 CPE contact hours
Application-Based Activity

Release date: March 8, 2023
BCPS posttest submission deadline: 11:59 p.m. (Central) on September 8, 2023.
ACPE posttest submission deadline: 11:59 p.m. (Central) on March 8, 2026.

TO EARN CPE/RECERTIFICATION CREDIT FROM THIS FEATURE
Posttest access: Purchase the required posttests (see below); then go to www.accp.com and sign in with your e-mail address and password. PSAP in JACCP features are listed under My Products on your My Account page.
Technical support is available from 8 a.m. to 5 p.m. (Central) weekdays by e-mail at [email protected].

Release Date: March 08, 2023
BCPS Deadline: September 08, 2023
ACPE Deadline: March 08, 2026

Format: Online Test

CPE Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American College of Clinical Pharmacy is approved by BPS as a provider for the recertification of BCPS.

BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/

To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.

The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.

The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.


Commercial Support

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.